Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Australian and New Zealand journal of psychiatry 2017-02, Vol.51 (2), p.198-198
Hauptverfasser:	Low, David Alvin, Xu, Jennifer, Tibrewal, Prashant, Bastiampillai, Tarun, Dhillon, Rohan
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Catatonia - drug therapy Catatonia - therapy Electroconvulsive Therapy Humans Infusions, Parenteral Lorazepam - administration & dosage Lorazepam - pharmacology Lorazepam - supply & distribution Male
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	198
container_issue	2
container_start_page	198
container_title	Australian and New Zealand journal of psychiatry
container_volume	51
creator	Low, David Alvin Xu, Jennifer Tibrewal, Prashant Bastiampillai, Tarun Dhillon, Rohan
description
doi_str_mv	10.1177/0004867416656806
format	Article
fullrecord	<record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_0004867416656806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0004867416656806</sage_id><sourcerecordid>10.1177_0004867416656806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c257t-bea70c24f989fb86adbd254381c2b5974273d2e6a71ab0d54fcf096723b364433</originalsourceid><addsrcrecordid>eNp1kLtOxDAURC0EYsNCT4X8AwG_YiflasVLWgkKaGiia8cBr_KS7SAtFb_B7_ElZLVAgUR1i5kzmjsInVJyTqlSF4QQkUslqJSZzIncQwkVgqRUUrGPkq2cbvUZOgphTQjlNFOHaMYUzwsiRYKe7sHbLloPDW56D292gPbz_SPgsYNXcA1o17i4wa7DizHEyecAQ1fh-GKxawcwEde9xwYixL5zBg8Q3RQZjtFBDU2wJ993jh6vLh-WN-nq7vp2uVilhmUqptqCIoaJusiLWucSKl2xTPCcGqazQompbMWsBEVBkyoTtalJIRXjmkshOJ8jsss1vg_B27ocvGvBb0pKyu1M5d-ZJuRshwyjbm31C_zsMhnSnSHAsy3X_ei76YX_A78AuHhxXw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Low, David Alvin ; Xu, Jennifer ; Tibrewal, Prashant ; Bastiampillai, Tarun ; Dhillon, Rohan</creator><creatorcontrib>Low, David Alvin ; Xu, Jennifer ; Tibrewal, Prashant ; Bastiampillai, Tarun ; Dhillon, Rohan</creatorcontrib><identifier>ISSN: 0004-8674</identifier><identifier>EISSN: 1440-1614</identifier><identifier>DOI: 10.1177/0004867416656806</identifier><identifier>PMID: 27389064</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Aged ; Catatonia - drug therapy ; Catatonia - therapy ; Electroconvulsive Therapy ; Humans ; Infusions, Parenteral ; Lorazepam - administration & dosage ; Lorazepam - pharmacology ; Lorazepam - supply & distribution ; Male</subject><ispartof>Australian and New Zealand journal of psychiatry, 2017-02, Vol.51 (2), p.198-198</ispartof><rights>The Royal Australian and New Zealand College of Psychiatrists 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c257t-bea70c24f989fb86adbd254381c2b5974273d2e6a71ab0d54fcf096723b364433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0004867416656806$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0004867416656806$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27389064$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Low, David Alvin</creatorcontrib><creatorcontrib>Xu, Jennifer</creatorcontrib><creatorcontrib>Tibrewal, Prashant</creatorcontrib><creatorcontrib>Bastiampillai, Tarun</creatorcontrib><creatorcontrib>Dhillon, Rohan</creatorcontrib><title>Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients</title><title>Australian and New Zealand journal of psychiatry</title><addtitle>Aust N Z J Psychiatry</addtitle><subject>Aged</subject><subject>Catatonia - drug therapy</subject><subject>Catatonia - therapy</subject><subject>Electroconvulsive Therapy</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Lorazepam - administration & dosage</subject><subject>Lorazepam - pharmacology</subject><subject>Lorazepam - supply & distribution</subject><subject>Male</subject><issn>0004-8674</issn><issn>1440-1614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOxDAURC0EYsNCT4X8AwG_YiflasVLWgkKaGiia8cBr_KS7SAtFb_B7_ElZLVAgUR1i5kzmjsInVJyTqlSF4QQkUslqJSZzIncQwkVgqRUUrGPkq2cbvUZOgphTQjlNFOHaMYUzwsiRYKe7sHbLloPDW56D292gPbz_SPgsYNXcA1o17i4wa7DizHEyecAQ1fh-GKxawcwEde9xwYixL5zBg8Q3RQZjtFBDU2wJ993jh6vLh-WN-nq7vp2uVilhmUqptqCIoaJusiLWucSKl2xTPCcGqazQompbMWsBEVBkyoTtalJIRXjmkshOJ8jsss1vg_B27ocvGvBb0pKyu1M5d-ZJuRshwyjbm31C_zsMhnSnSHAsy3X_ei76YX_A78AuHhxXw</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Low, David Alvin</creator><creator>Xu, Jennifer</creator><creator>Tibrewal, Prashant</creator><creator>Bastiampillai, Tarun</creator><creator>Dhillon, Rohan</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201702</creationdate><title>Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients</title><author>Low, David Alvin ; Xu, Jennifer ; Tibrewal, Prashant ; Bastiampillai, Tarun ; Dhillon, Rohan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c257t-bea70c24f989fb86adbd254381c2b5974273d2e6a71ab0d54fcf096723b364433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Catatonia - drug therapy</topic><topic>Catatonia - therapy</topic><topic>Electroconvulsive Therapy</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Lorazepam - administration & dosage</topic><topic>Lorazepam - pharmacology</topic><topic>Lorazepam - supply & distribution</topic><topic>Male</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Low, David Alvin</creatorcontrib><creatorcontrib>Xu, Jennifer</creatorcontrib><creatorcontrib>Tibrewal, Prashant</creatorcontrib><creatorcontrib>Bastiampillai, Tarun</creatorcontrib><creatorcontrib>Dhillon, Rohan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Australian and New Zealand journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Low, David Alvin</au><au>Xu, Jennifer</au><au>Tibrewal, Prashant</au><au>Bastiampillai, Tarun</au><au>Dhillon, Rohan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients</atitle><jtitle>Australian and New Zealand journal of psychiatry</jtitle><addtitle>Aust N Z J Psychiatry</addtitle><date>2017-02</date><risdate>2017</risdate><volume>51</volume><issue>2</issue><spage>198</spage><epage>198</epage><pages>198-198</pages><issn>0004-8674</issn><eissn>1440-1614</eissn><cop>London, England</cop><pub>SAGE Publications</pub><pmid>27389064</pmid><doi>10.1177/0004867416656806</doi><tpages>1</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0004-8674
ispartof	Australian and New Zealand journal of psychiatry, 2017-02, Vol.51 (2), p.198-198
issn	0004-8674 1440-1614
language	eng
recordid	cdi_crossref_primary_10_1177_0004867416656806
source	MEDLINE; SAGE Complete
subjects	Aged Catatonia - drug therapy Catatonia - therapy Electroconvulsive Therapy Humans Infusions, Parenteral Lorazepam - administration & dosage Lorazepam - pharmacology Lorazepam - supply & distribution Male
title	Parenteral lorazepam’s unavailability in Australia and the impact for catatonic patients
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T06%3A49%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parenteral%20lorazepam%E2%80%99s%20unavailability%20in%20Australia%20and%20the%20impact%20for%20catatonic%20patients&rft.jtitle=Australian%20and%20New%20Zealand%20journal%20of%20psychiatry&rft.au=Low,%20David%20Alvin&rft.date=2017-02&rft.volume=51&rft.issue=2&rft.spage=198&rft.epage=198&rft.pages=198-198&rft.issn=0004-8674&rft.eissn=1440-1614&rft_id=info:doi/10.1177/0004867416656806&rft_dat=%3Csage_cross%3E10.1177_0004867416656806%3C/sage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27389064&rft_sage_id=10.1177_0004867416656806&rfr_iscdi=true